May 4, 2022
Happy to announce that Enzyre has been granted REACT-EU funding. Looking forward to develop a modular pilot production line for our #EnzyPad and #EnzyCard together with our partners Demcon industrial systems, Surfix Diagnostics and Micronit!
Written by
Share this article
Enzyre is now preparing to raise an investment round. The proceeds will be used to (a) finalize the development of the ENZYPAD en ENZYCARD Hemophilia A, (b) manufacture the portable instrument & disposable, and (c) perform studies to obtain regulatory approval in EU & US. The product will be commercialized worldwide with support of our pharma partner. Interested candidate investors are encouraged to contact us at investors@enzyre.com.
Get involved
Enzyre BV
Transistorweg 5
6534-AT Nijmegen
The Netherlands
